Chiropractic Offers Long Term Benefits for Fibromyalgia Sufferers

If you suffer with fibromyalgia, you are not alone, as Dr. Aazami sees many patients with this particular syndrome in our Hyattsville, District Heights chiropractic clinic. Actually, the Centers for Disease Control and Prevention (CDC) estimates that roughly two percent of all adults in the US have fibromyalgia issues. Fortunately, chiropractic adjustments is one treatment option that can provide positive results.

Research Supports Chiropractic Care Reduces Fibromyalgia Issues

In a study released in mid-2015, 215 adults with fibromyalgia were assessed based on factors ranging from pain to quality of sleep to the levels of depression symptoms or anxiety they felt. Then they were divided into two groups with one group receiving a multi-modal treatment program for three months and the second group receiving the same program plus chiropractic adjustments (specifically, to the upper neck area) for the same length of time.

The individuals who received chiropractic adjustments combined with the multi-modal treatment program reported greater results in all areas (pain, sleep, depression, and anxiety) at 12 weeks post-treatment when compared to the study people who received multi-modal treatment without chiropractic therapy. Additionally, those positive outcomes were lasting as the patients reported continued improvement one full year later.

Fibromyalgia pain can significantly decrease your quality of life, both mentally and physically. If you're dealing with fibromyalgia, we might be able to help.

You don't have to suffer! To learn what Dr. Aazami can do for your fibromyalgia problems, call our Hyattsville, District Heights chiropractic office today.

Research

• Fibromyalgia. Centers for Disease Control and Prevention. Retrieved from http://www.cdc.gov/arthritis/basics/fibromyalgia.htm on November 2, 2015.
• Moustafa I & Diab A. (2015, July). The addition of upper cervical manipulative therapy in the treatment of patients with fibromyalgia: a randomized controlled trial. Rheumatology International;35(7):1163-74.